ThyroPIX – New generation of the camera for the thyroid gland and small organs imaging by nuclear medicine methods.
The project is part of the 1. Public contest for industrial and experimental development program TREND organized by TAČR. It took the 11th place amongst all 396 projects submitted in this contest. The project is scheduled for 4 years, beginning in 2020.
The consortium was established upon the previous long-term cooperation of all the incorporated companies.
Advacam s.r.o. is the leader of the project, having successfully completed several projects in the past – not only in Czech Republic, but on an international scale as well. ADVACAM is responsible for the part dedicated to the development of the detectors and advanced imaging methods.
The other members of the consortium are:
- Radalytica a.s.: integration of the imaging system into the final solution within developing the control software and imaging software
- Czech metrology institute: Monte Carlo simulations and imaging methodology
- Charles University, 1. Medical Faculty, Center of advanced preclinical imaging: preclinical tests on small animals
- University hospital in Motol, Clinic of nuclear medicine and endocrinology: clinical tests on human patients
The main goal of the project is to develop a new mobile robotic imaging camera prototype for thyroid gland and small organ imaging by nuclear medicine methods in diagnostic and therapeutic procedures in human medicine. ThyroPIX will bring an efficient instrument to meet the 2018/02 implemented EU ordinance 2013/59/EURATOM requirements on radiation therapy planning and verification, which is problematical in nuclear medicine methods.
The major concern in design and development will be to eliminate any known limitations and disadvantages, which prevents the therapeutic centers to meet the requirements of the legislations. This will consequently enable the application of principals of personalized medicine in administration of the therapeutic radio-pharmaceuticals.